Propofol infusion syndrome all except?
The core concept here is understanding the pathophysiology and clinical manifestations of PRIS. Propofol is a sedative used in anesthesia and intensive care. Prolonged infusions, especially at high rates, can lead to PRIS. The exact mechanism isn't fully understood, but it's thought to involve mitochondrial dysfunction and lipid metabolism issues due to the emulsifier in propofol (sodium hydroxide).
Now, the options are missing, but I need to think about common features and which one might be an exception. Let's consider typical features. Metabolic acidosis is a hallmark. Rhabdomyolysis with elevated CK and myoglobinuria. Hyperkalemia from rhabdo. Cardiac failure, sometimes with arrhythmias. Hypotension. Coagulopathy isn't typically a feature. So if one of the options lists coagulopathy, that would be the exception. Alternatively, maybe hepatic steatosis is a feature, but I'm not sure. Another possible exception could be something like hypokalemia, which isn't part of PRIS.
Wait, the user didn't provide the options, so I need to think of common distractors. Let me list possible options that might be presented. For example:
A. Metabolic acidosis
B. Hyperkalemia
C. Coagulopathy
D. Rhabdomyolysis
In this case, the answer would be C because coagulopathy isn't a typical feature of PRIS. Alternatively, if one of the options is hypokalemia, that would be incorrect. But I need to be precise. Let me verify: PRIS is characterized by metabolic acidosis, rhabdomyolysis, hyperkalemia, acute kidney injury, cardiac failure, and sometimes myoglobinuria. Coagulopathy isn't a standard feature. So if an option includes coagulopathy, that's the exception.
Therefore, the correct answer would be the option that lists coagulopathy. The incorrect options would be the other features. The clinical pearl is to remember that PRIS is a rare but severe condition requiring monitoring for prolonged propofol use. The key is to identify which feature is not associated.
**Core Concept**
Propofol infusion syndrome (PRIS) is a rare but potentially fatal condition caused by prolonged high-dose propofol infusions. It is characterized by metabolic acidosis, rhabdomyolysis, hyperkalemia, acute kidney injury, and cardiac failure. The pathophysiology involves mitochondrial dysfunction and lipid accumulation.
**Why the Correct Answer is Right**
The correct answer is the feature **not** associated with PRIS. For example, if an option lists **coagulopathy**, this is incorrect because PRIS does not typically involve bleeding disorders or coagulopathy. Classic features include metabolic